G-QUADRUPLEX LIGANDS AS STABILIZER TARGETING TELOMERASE ENZYME AS ANTI CANCER AGENTS
DOI:
https://doi.org/10.22159/ajpcr.2017.v10i8.19797Keywords:
Perylene derivatives, G-Quadruplex, Telomerase, AnticancerAbstract
The human telomere stabilization with G-Quadruplex DNA tends to induce apoptosis. The molecular target of telomere cascade with a rigid molecular may show efficacious to treat cancer. The study of intercalation to human telomeric DNA with proposed ligand can be evaluated by the help of biophysical studies and biological studies. G-Quadruplex is one of the key epigenetic episodes of eukaryotes and prokaryotes, generally found in the telomeric end region, immunoglobulin switch recombination and the lagging strand of the DNA. These chemotherapeutic advances are not enough to maintain a life expectancy of cancer affected patients. A number of G-Quadruplex ligands such as acridine, perylene, and anthraquinones have been synthesized reported and evaluated them for the inhibitor activity. Therefore, translational research can pave the novel prospect to treat cancer in a fundamental way. In that connection, basic research showed G-Quadruplex phenomenon of DNA, which is having a great impact in this chemotherapy.
Downloads
Author Biography
Hemalatha Cn, Department of Pharmaceutical Chemistry and Analysis, School of Pharmaceutical Sciences, Vels University, Chennai, Tamil Nadu, India.
Professor and Head
Department of Pharmaceutical Chemistry and Analysis
References
Chu B, Yuan G, Zhou J, Ou Y, Zhu P. A new telomerase inhibitor and apoptosis-inducing agent in leukemia: Perylene derivative as G-quadruplex ligand Tel03. Drug Dev Res 2008;69:235-41.
Miyoshi D, Nakao A, Toda T, Sugimoto N. Effect of divalent cations on the anti-parallel G-Quartet structure of d-(G4T4G4). FEBS Lett 2001;25:3341-6.
Keniry MA. Quadruplex structures in nucleic acids. Biopolymers 2000- 2001;56:123-46.
Mergny JL, Helene C. G-quadruplex DNA: A target for drug design. Nat Med 1998;4:1366.
Rossetti L, Franceschin M, Bianco A, Ortaggi G, Savino M. Perylene diimides with different side chains are selective in inducing different G-quadruplex DNA structures and in inhibiting telomerase. Bioorg Med Chem Lett 2002;12(18):2527-33.
Harley CB. Telomerase and cancer therapeutics. Nat Rev Cancer 2008;8:167-79.
Xu Y. Chemistry in human telomere biology: Structure, function and targeting of telomere DNA/RNA. Chem Soc Rev 2011;40(5):2719-40.
Puri N, Girard J. Novel therapeutics targeting telomerase and telomeres. J Cancer 013;5:10.
Sun D, Thompson B, Cathers BE, Salazar M, Kerwin SM, Trent JO, et al. Inhibition of human telomerase by a G-quadruplex-interactive compound. J Med Chem 1997;40:2113-6.
Sissi GZ, Lucatello L, Pivetta C, Cadamuro SA, Fox KR, Neidle S, et al. Aminoacyl-anthraquinone conjugates as telomerase inhibitors: Synthesis, biophysical and biological evaluation. J Med Chem 2008;51:5566-74.
Shchekotikhin AE, Glazunov VA, Dezhenkova LG, Luzhkov YN, Sinkevich YB, Kovalenko LV, et al. Synthesis and cytotoxic properties of 4,11-bis[(aminoethyl)amino]anthra[2,3b]thiophene-5,10-diones, novel analogs of antitumor anthracene-9,10diones. Bioorg Med Chem 2009;17:1861-9.
Harrison RJ, Gowan SM, Kelland LR, Neidle S. Human telomerase inhibition by substituted acridine derivatives. Bioorg Med Chem Lett 1999;9:2463-8.
Read MA, Wood AA, Harrison RJ, Gowan SM, Kelland LR, Dosanjh HS, et al. Molecular modeling studies on G-quadruplex complexes of telomerase inhibitors: Structure-activity relationships. J Med Chem 1999;42:4538-46.
Read M, Harrison RJ, Romagnoli B, Tanious FA, Gowan SH, Reszka AP, et al. Structure-based design of selective and potent G-quadruplex-mediated telomerase inhibitors. Proc Natl Acad Sci U S A 2001;98(9):4844-9.
Heald RA, Modi C, Cookson JC, Hutchinson I, Laughton CA, Gowan SM, et al. Antitumor polycyclic acridines. 8.1 synthesis and telomerase-inhibitory activity of methylated pentacyclic acridinium salts. J Med Chem 2002;45:590-7.
Heald RA, Stevens MF. Antitumour polycyclic acridines. Palladium(0) mediated syntheses of quino[4,3,2-kl]acridines bearing peripheral substituents as potential telomere maintenance inhibitors. Org Biomol Chem 2003;1:3377-89.
Cheng MK, Modi C, Cookson JC, Hutchinson I, Heald RA, McCarroll AJ, et al. Antitumor polycyclic acridines 20. Search for DNA G-quadruplex binding selectivity in a series of 8,13-dimethylquino[4,3,2-kl]acridinium salts: Telomere-targeted agents. J Med Chem 2008;51(4):963-75.
Harrison RJ, Cuesta J, Chessari G, Read MA, Basra SK, Reszka AP, et al. Trisubstituted acridine derivatives as potent and selective telomerase
Fedoroff OY, Salazar M, Han H, Chemeris VV, Kerwin SM, Hurley LH. NMR-based model of a telomerase-inhibiting compound bound to G-quadruplex DNA. Biochemistry 1998;37:12367-74.
Kerwin SM, Chen G, Kern JT, Thomas PW. Perylene diimide G-quadruplex DNA binding selectivity is mediated by ligand aggregation. Bioorg Med Chem Lett 2002;12:447-50.
Rossetti L, Franceschin M, Schirripa S, Bianco A, Ortaggi G, Savino M. Selective interactions of perylene derivatives having different side chains with inter - And intramolecular G-quadruplex DNA structures. A correlation with telomerase inhibition. Bioorg Med Chem Lett 2005;15:413-20.
Franceschin M, Pascucci E, Alvino A, D’Ambrosio D, Bianco A, Ortaggi G, et al. New highly hydrosoluble and not self-aggregated perylene derivatives with three and four polar side-chains as G-quadruplex telomere targeting agents and telomerase inhibitors. Bioorg Med Chem Lett 2007;17:2515-22.
Franceschin M, Lombardo CM, Pascucci E, D’Ambrosio D, Micheli E, Bianco A, et al. The number and distances of positive charges of polyamine side chains in a series of perylene diimides significantly influence their ability to induce G-quadruplex structures and inhibit human telomerase. Bioorg Med Chem 2008;16:2292-304.
Wheelhouse RT, Sun D, Han H, Han FX, Hurley LH. Cationic porphyrins as telomerase inhibitors: The interaction of tetra-(N-methyl-4pyridyl) porphine with quadruplex DNA. J Am Chem Soc 1998;120:3261-2.
Shi DF, Wheelhouse RT, Sun D, Hurley LH. Quadruplex-interactive agents as telomerase inhibitors: Synthesis of porphyrins and structure-activity relationship for the inhibition of telomerase. J Med Chem 2001;44:4509-23.
Sasaki S, Ehara T, Sakata I, Fujino Y, Harada N, Kimura J, et al. Development of novel telomerase inhibitors based on a bisindole unit. Bioorg Med Chem Lett 2001;11(4):583-5.
Ma Y, Ou TM, Tan JH, Hou JQ, Huang SL, Gu LQ, et al. Synthesis and evaluation of 9-O-substituted berberine derivatives containing aza-aromatic terminal group as highly selective telomeric G-quadruplex stabilizing ligands. Bioorg Med Chem Lett 2009;19:3414-7.
Franceschin M, Rossetti L, D’Ambrosio A, Schirripa S, Bianco A, Ortaggi G, et al. Natural and synthetic G-quadruplex interactive berberine derivatives. Bioorg Med Chem Lett 2006;16(6):1707-11.
Shin-Ya K, Wierzba K, Matsuo KI, Ohtani T, Yamada Y, Furihata K, et al. Telomestatin, a novel telomerase inhibitor from Streptomyces annulus. J Am Chem Soc 2001;123:1262-3.
Kim MY, Vankayalapati H, Shin-Ya K, Wierzba K, Hurley LH. Telomestatin, a potent telomerase inhibitor that interacts quite specifically with the human telomeric intramolecular G-quadruplex. J Am Chem Soc 2002;124(10):2098-9.
Barbieri CM, Srinivasan AR, Rzuczek SG, Rice JE, Lavoie EJ, Pilch DS. Defining the mode, energetics and specificity with which a macrocyclic hexaoxazole binds to human telomeric G-quadruplex DNA. Nucleic Acids Res 2007;35:3272-86.
Tera M, Sohtome Y, Ishizuka H, Doi T, Takagi M, Shin-Ya K, et al. Design and synthesis of telomestatin derivatives and their inhibitory activity of telomerase. Heterocycles 2006;69:505-14.
Riou JF, Guittat L, Mailliet P, Laoui A, Renou E, Petitgenet O, et al. Cell senescence and telomere shortening induced by a new series of specific G-quadruplex DNA ligands. Proc Natl Acad Sci U S A 2002;99(5):2672-7.
Balijepalli1 MK, Buru AS, Sakirolla R, Pichika MR. Cinnamomum genus: A review on its biological activities. Int J Pharm Pharm Sci 2017;9(2):1-11.
Nerdy, Putra ED, Haro G, Harahap U, Hutagaol R, Karsono. In silico screening of hesperetin and naringenin ester derivatives as anticancer against p-glycoprotein. Int J Pharm Pharm Sci 2015;7(2):485-8.
Published
How to Cite
Issue
Section
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.
